Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppress
about
Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppress
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study to Evaluate Switching Fr ...... imen in Virologically Suppress
@en
type
label
Study to Evaluate Switching Fr ...... imen in Virologically Suppress
@en
prefLabel
Study to Evaluate Switching Fr ...... imen in Virologically Suppress
@en
P17
P4844
P6153
P131
P1476
A Phase 3b Randomized, Open La ...... essed, HIV 1 Infected Patients
@en
P17
P3098
NCT01495702
P580
2011-12-01T00:00:00Z
P582
2013-11-01T00:00:00Z